Cart
sales@molnova.com
7-Troc-paclitaxel
CAS No. 114915-17-2
7-Troc-paclitaxel( 7 Troc paclitaxel )
Catalog No. M27342 CAS No. 114915-17-2
7-Troc-paclitaxel is a precursor of paclitaxel which has anti-tumor activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 78 | In Stock |
|
| 2MG | 29 | In Stock |
|
| 5MG | 41 | In Stock |
|
| 10MG | 59 | In Stock |
|
| 25MG | 98 | In Stock |
|
| 50MG | 141 | In Stock |
|
| 100MG | 211 | In Stock |
|
| 200MG | 314 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name7-Troc-paclitaxel
-
NoteResearch use only, not for human use.
-
Brief Description7-Troc-paclitaxel is a precursor of paclitaxel which has anti-tumor activity.
-
Description7-Troc-paclitaxel is a precursor of paclitaxel which has anti-tumor activity.
-
In Vitro——
-
In Vivo——
-
Synonyms7 Troc paclitaxel
-
PathwayOthers
-
TargetOther Targets
-
RecptorTNKS1|TNKS2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number114915-17-2
-
Formula Weight1029.31
-
Molecular FormulaC50H52Cl3NO16
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES[H][C@@]12C[C@H](OC(=O)OCC(Cl)(Cl)Cl)[C@@]3(C)C(=O)[C@H](OC(C)=O)C4=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)c5ccccc5)[C@]3([H])[C@@]1(CO2)OC(C)=O)C4(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)c1ccccc1)c1ccccc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Okada-Iwasaki R, et al. The Discovery and Characterization of K-756, a Novel Wnt/β-Catenin Pathway Inhibitor Targeting Tankyrase. Mol Cancer Ther. 2016 Jul;15(7):1525-34.
molnova catalog
related products
-
2-heptyl-3-hydroxy-4...
2-heptyl-3-hydroxy-4(1H)-Quinolone (Pseudomonas Quinolone Signal) is a quorum-sensing signalling molecule produced by Pseudomonas aeruginosa in response to increased cell density.
-
Clorsulon
Clorsulon is used in the treatment of Fasciola hepatica infections in calves and sheep.
-
IGF-I Analog
JB-1, an IGF-1 peptide analog, is a selective and potent IGF-1R antagonist. JB-1 competes with IGF-1 by binding the IGF-1 receptor. JB-1 prevents the autophosphorylation of IGF-1R, and has no activity in IGF-II.
